Oncology & Cancer

Potential lines of attack against prostate cancer

Researchers from The University of East Anglia (UEA) have contributed to the world's largest study into genes that drive prostate cancer – identifying 80 molecular weaknesses that could be targeted by drugs to treat the ...

Oncology & Cancer

Rare bacteria boosts immunotherapy in prostate cancer

A unique bacterial strain isolated from a patient with pelvic pain may represent a promising path to treating prostate cancer with immunotherapy, according to a Northwestern Medicine study published in Nature Communications.

Oncology & Cancer

Statins may do double duty on heart disease and cancer

About 40 million adults in the U.S. take a statin to lower their cholesterol and reduce the risk for heart disease. They might also be getting an added anti-cancer benefit, a growing body of evidence suggests.

page 9 from 40